These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
562 related items for PubMed ID: 15115499
1. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides. Child FJ, Mitchell TJ, Whittaker SJ, Scarisbrick JJ, Seed PT, Russell-Jones R. Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499 [Abstract] [Full Text] [Related]
2. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides. Ponte P, Serrão V, Apetato M. J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938 [Abstract] [Full Text] [Related]
3. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma. Geskin L. Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808 [Abstract] [Full Text] [Related]
4. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. Wilson LD, Jones GW, Kim D, Rosenthal D, Christensen IR, Edelson RL, Heald PW, Kacinski BM. J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224 [Abstract] [Full Text] [Related]
5. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA). Soung J, Muigai W, Amin N, Stern DK, Lebwohl MG. J Drugs Dermatol; 2005 Jul; 4(3):290-4. PubMed ID: 15898283 [Abstract] [Full Text] [Related]
6. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides. Wackernagel A, Hofer A, Legat F, Kerl H, Wolf P. Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785 [Abstract] [Full Text] [Related]
7. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group. Thomsen K, Hammar H, Molin L, Volden G. Acta Derm Venereol; 1989 Mar; 69(6):536-8. PubMed ID: 2575334 [Abstract] [Full Text] [Related]
12. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study. Ahmad K, Rogers S, McNicholas PD, Collins P. Acta Derm Venereol; 2007 Oct; 87(5):413-7. PubMed ID: 17721648 [Abstract] [Full Text] [Related]
16. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Mostow EN, Neckel SL, Oberhelman L, Anderson TF, Cooper KD. Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078 [Abstract] [Full Text] [Related]
17. Efficacy of treatments for mycosis fungoides and Sézary syndrome: nationwide survey responses. Gettler SL, Fung MA. Dermatol Online J; 2005 Dec 01; 11(3):6. PubMed ID: 16409902 [Abstract] [Full Text] [Related]
18. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides. Weber F, Schmuth M, Sepp N, Fritsch P. Acta Derm Venereol; 2005 Dec 01; 85(4):329-32. PubMed ID: 16191854 [Abstract] [Full Text] [Related]
19. Extracorporeal photophoresis: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2006 Dec 01; 6(6):1-82. PubMed ID: 23074497 [Abstract] [Full Text] [Related]
20. Photochemotherapy in cutaneous T cell lymphoma and parapsoriasis en plaques. Long-term follow-up in forty-three patients. Rosenbaum MM, Roenigk HH, Caro WA, Esker A. J Am Acad Dermatol; 1985 Oct 01; 13(4):613-22. PubMed ID: 3878369 [Abstract] [Full Text] [Related] Page: [Next] [New Search]